Volume 63, Issue 5 pp. 631-639
INVITED REVIEW

Challenges in diagnosing coexisting ocular myasthenia gravis and thyroid eye disease

Benjamin Claytor MD

Benjamin Claytor MD

Neuromuscular Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA

Search for more papers by this author
Yuebing Li MD, PhD

Corresponding Author

Yuebing Li MD, PhD

Neuromuscular Center, Neurological Institute, Cleveland Clinic, Cleveland, Ohio, USA

Correspondence

Yuebing Li, Neuromuscular Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Desk S90, Cleveland, Ohio 44195.

Email: [email protected]

Search for more papers by this author
First published: 27 November 2020
Citations: 6
The objectives of this activity are to: 1) Understand why the co-existence of ocular myasthenia gravis and thyroid eye disease may present diagnostic challenges, and take this into consideration when evaluating patients; 2) Distinguish on examination the clinical features of thyroid eye disease from those of ocular myasthenia gravis; 3) Apply multimodal evaluation to these patients in the clinical setting, including examination, imaging, blood tests, and physiological tests.

Abstract

Ocular myasthenia gravis (OMG) and thyroid eye disease are two autoimmune conditions that have several overlapping clinical features, and these coexist with a small but not insignificant frequency. Segregating these diagnoses is typically straightforward, but, when the two diseases co-occur in the same individual, making a diagnosis of OMG can be very challenging. In this review we address what is known about the coexistence of OMG and thyroid eye disease and we highlight the clinical features that are suggestive of overlapping conditions. We also describe the major testing approaches used in the diagnosis of these two entities, with special emphasis on the potential shortcomings of individual tests in patients with overlapping disease. In patients with thyroid eye disease, securing a diagnosis of OMG may not be possible on the basis of a single positive test. A multimodal approach using clinical, serologic, imaging, and electrodiagnostic data, is typically required.

CONFLICT OF INTEREST

Y.L. has served as a consultant for Argenx. B.C. declares no conflicts of interest.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me